Crescita Therapeutics (TSX:CTX) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $5.955 million in sales this quarter. This is a 13.72 percent decrease over sales of $6.902 million the same period last year.